UA85041C2 - Способ лечения кишечной непроходимости - Google Patents
Способ лечения кишечной непроходимостиInfo
- Publication number
- UA85041C2 UA85041C2 UA20041109277A UA20041109277A UA85041C2 UA 85041 C2 UA85041 C2 UA 85041C2 UA 20041109277 A UA20041109277 A UA 20041109277A UA 20041109277 A UA20041109277 A UA 20041109277A UA 85041 C2 UA85041 C2 UA 85041C2
- Authority
- UA
- Ukraine
- Prior art keywords
- ileus
- treating
- patient
- pharmaceutical composition
- carbon monoxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к отрасли медицины и касается способов лечения кишечной непроходимости (илеуса) у пациента, который предусматривают введение фармацевтической композиции, содержащей окись углерода, пациенту. Также изобретение касается применения эффективного количества окиси углерода для изготовления фармацевтической композиции для лечения илеуса у пациента.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37265202P | 2002-04-15 | 2002-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA85041C2 true UA85041C2 (ru) | 2008-12-25 |
Family
ID=29250888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041109277A UA85041C2 (ru) | 2002-04-15 | 2003-02-21 | Способ лечения кишечной непроходимости |
Country Status (15)
Country | Link |
---|---|
US (1) | US7687079B2 (ru) |
EP (1) | EP1499333B1 (ru) |
JP (1) | JP4588325B2 (ru) |
CN (1) | CN100496509C (ru) |
AU (1) | AU2003216368B2 (ru) |
CA (1) | CA2481972A1 (ru) |
EA (1) | EA200401365A1 (ru) |
ES (1) | ES2546280T3 (ru) |
HR (1) | HRP20040972A2 (ru) |
MX (1) | MXPA04010243A (ru) |
NO (1) | NO20044562L (ru) |
PL (1) | PL373002A1 (ru) |
RS (1) | RS91004A (ru) |
UA (1) | UA85041C2 (ru) |
WO (1) | WO2003088923A2 (ru) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
WO2003000114A2 (en) * | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
JP2005519928A (ja) * | 2002-02-04 | 2005-07-07 | ハース,ベルナー | Co放出能力を有する化合物の投与によって哺乳動物を治療する方法と、co放出能力を有する化合物ならびにその医薬組成物 |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
PL374241A1 (en) | 2002-04-15 | 2005-10-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
JP2005522521A (ja) | 2002-04-15 | 2005-07-28 | ベス イスラエル デアコネス メディカル センター | ヘムオキシゲナーゼ−1およびヘム分解産物の使用法 |
MXPA04010243A (es) | 2002-04-15 | 2005-07-05 | Univ Pittsburgh | Metodos para tratar ileo. |
DK1505990T3 (da) | 2002-05-17 | 2011-11-21 | Univ Yale | Fremgangsmåder til behandling af hepatitis |
PL374375A1 (en) * | 2002-06-05 | 2005-10-17 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
AU2003279236B8 (en) * | 2002-06-21 | 2009-02-19 | Beth Israel Deaconess Medical Center, Inc. | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
MXPA05004924A (es) * | 2002-11-07 | 2005-08-18 | Univ Pittsburgh | Tratamiento para shock hemorragico. |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
US7523752B2 (en) | 2005-09-21 | 2009-04-28 | Ino Therapeutics, Llc | System and method of administering a pharmaceutical gas to a patient |
US8893717B2 (en) | 2005-09-21 | 2014-11-25 | Ino Therapeutics Llc | Systems and methods of administering a pharmaceutical gas to a patient |
WO2007073225A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda. | Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
LT3210644T (lt) | 2009-05-27 | 2019-02-11 | Ino Therapeutics Llc | Įrenginiai, skirti sugraduoto vožtuvo ir hermetiško kanistro įrenginio sukabinimui be sandariklio |
JP2011010865A (ja) | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
EP3583851A1 (en) | 2011-01-14 | 2019-12-25 | Children's Hospital Los Angeles | Solution of carbon monoxide for treatment of disease, including sickle cell disease |
JP5978291B2 (ja) | 2011-04-19 | 2016-08-24 | アルファーマ インコーポレイテッドAlfama,Inc. | 一酸化炭素放出分子およびその使用 |
EP2734235B1 (en) | 2011-07-21 | 2017-03-22 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
JP2014525399A (ja) | 2011-08-09 | 2014-09-29 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Dna損傷を処置する方法 |
AU2013231976B9 (en) | 2012-03-15 | 2017-12-14 | Mallinckrodt Hospital Products IP Limited | Methods of administering high concentrations of nitric oxide |
TW201618795A (zh) * | 2014-04-15 | 2016-06-01 | 波泰里斯股份有限公司 | 用以改良器官功能及延長器官移植物壽命之系統及方法 |
US20150328073A1 (en) * | 2014-05-19 | 2015-11-19 | Joseph Gerard Archer | Hyperbaric Social Establishment or Residence |
US11771855B2 (en) * | 2017-01-10 | 2023-10-03 | Brian Charles Weiner | Methods of treating medical conditions with oxygen |
JP6618976B2 (ja) * | 2017-11-14 | 2019-12-11 | イノ セラピューティクス エルエルシー | 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法 |
JP2021525246A (ja) * | 2018-05-23 | 2021-09-24 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 心臓特異的標的化ペプチド(ctp)、組成物およびその使用 |
US11576929B2 (en) | 2018-06-08 | 2023-02-14 | Sumitomo Seika Chemicals Co., Ltd. | Composition for inflammatory gastrointestinal disorders |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
JPS5679957A (en) | 1979-12-05 | 1981-06-30 | Sogo Seibutsu Igaku Kenkyusho:Kk | Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
ES2219646T5 (es) * | 1993-02-22 | 2008-11-01 | Abraxis Bioscience, Inc. | Metodos para la administracion in vivo de compuestos biologicos y composiciones utiles para los mismos. |
EP0804244A1 (en) | 1993-03-26 | 1997-11-05 | Biorelease Technologies, Inc. | Compositions including heme-containing proteins and methods relating thereto |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
DE4421433C1 (de) * | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
WO1997002036A1 (en) * | 1995-06-30 | 1997-01-23 | Zymogenetics, Inc. | 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
PT914103E (pt) * | 1996-04-05 | 2006-09-29 | Gen Hospital Corp | Tratamento de uma hemoglobinopatia |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
ATE253372T1 (de) | 1996-08-27 | 2003-11-15 | Messer Griesheim Gmbh | Wasserstoffhaltiges medikament |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US6315995B1 (en) | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
EP0951292B1 (en) * | 1996-09-27 | 2007-04-04 | The Trustees of Columbia University in the City of New York | Treating an ischemic disorder and improving stroke outcome |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
EP1357120A1 (en) | 1998-03-16 | 2003-10-29 | Celgene Corporation | 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
FR2812197B1 (fr) | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
FR2816212A1 (fr) | 2000-11-03 | 2002-05-10 | Air Liquide Sante Int | Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire |
US20040197271A1 (en) * | 2001-03-20 | 2004-10-07 | Kunka Robert Leonard | Inhalation drug combinations |
CN1507348A (zh) * | 2001-03-30 | 2004-06-23 | ɣ����ҽҩ��˾ | 用于治疗血管性、炎性和免疫疾病的一氧化碳生成性组合物 |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
WO2002096387A1 (en) * | 2001-05-25 | 2002-12-05 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
WO2003000114A2 (en) * | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
JP2005519928A (ja) * | 2002-02-04 | 2005-07-07 | ハース,ベルナー | Co放出能力を有する化合物の投与によって哺乳動物を治療する方法と、co放出能力を有する化合物ならびにその医薬組成物 |
UA86344C2 (ru) | 2002-02-13 | 2009-04-27 | Бет Ізрейел Діконісс Медікал Сентер, Інк. | Способ лечения сосудистых заболеваний |
JP2005522521A (ja) * | 2002-04-15 | 2005-07-28 | ベス イスラエル デアコネス メディカル センター | ヘムオキシゲナーゼ−1およびヘム分解産物の使用法 |
PL374241A1 (en) | 2002-04-15 | 2005-10-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
MXPA04010243A (es) | 2002-04-15 | 2005-07-05 | Univ Pittsburgh | Metodos para tratar ileo. |
EP1501523A4 (en) | 2002-05-09 | 2006-12-13 | Univ Yale | CARBON MONOXIDE AS A BIOMARKER AND THERAPEUTIC AGENT |
DK1505990T3 (da) | 2002-05-17 | 2011-11-21 | Univ Yale | Fremgangsmåder til behandling af hepatitis |
PL374375A1 (en) | 2002-06-05 | 2005-10-17 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
AU2003279236B8 (en) * | 2002-06-21 | 2009-02-19 | Beth Israel Deaconess Medical Center, Inc. | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
DE10230165A1 (de) | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
MXPA05004924A (es) | 2002-11-07 | 2005-08-18 | Univ Pittsburgh | Tratamiento para shock hemorragico. |
-
2003
- 2003-02-21 MX MXPA04010243A patent/MXPA04010243A/es active IP Right Grant
- 2003-02-21 PL PL03373002A patent/PL373002A1/xx not_active Application Discontinuation
- 2003-02-21 CN CNB038126621A patent/CN100496509C/zh not_active Expired - Fee Related
- 2003-02-21 RS YUP-910/04A patent/RS91004A/sr unknown
- 2003-02-21 US US10/371,666 patent/US7687079B2/en not_active Expired - Fee Related
- 2003-02-21 EP EP03746917.8A patent/EP1499333B1/en not_active Expired - Lifetime
- 2003-02-21 JP JP2003585676A patent/JP4588325B2/ja not_active Expired - Fee Related
- 2003-02-21 ES ES03746917.8T patent/ES2546280T3/es not_active Expired - Lifetime
- 2003-02-21 AU AU2003216368A patent/AU2003216368B2/en not_active Ceased
- 2003-02-21 UA UA20041109277A patent/UA85041C2/ru unknown
- 2003-02-21 CA CA002481972A patent/CA2481972A1/en not_active Abandoned
- 2003-02-21 EA EA200401365A patent/EA200401365A1/ru unknown
- 2003-02-21 WO PCT/US2003/005428 patent/WO2003088923A2/en active IP Right Grant
-
2004
- 2004-10-15 HR HR20040972A patent/HRP20040972A2/hr not_active Application Discontinuation
- 2004-10-22 NO NO20044562A patent/NO20044562L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003088923A2 (en) | 2003-10-30 |
WO2003088923A3 (en) | 2004-05-06 |
NO20044562L (no) | 2004-11-15 |
EP1499333A2 (en) | 2005-01-26 |
EA200401365A1 (ru) | 2005-04-28 |
AU2003216368A1 (en) | 2003-11-03 |
ES2546280T3 (es) | 2015-09-22 |
CN1658889A (zh) | 2005-08-24 |
CN100496509C (zh) | 2009-06-10 |
US7687079B2 (en) | 2010-03-30 |
MXPA04010243A (es) | 2005-07-05 |
RS91004A (en) | 2007-02-05 |
HRP20040972A2 (en) | 2005-06-30 |
EP1499333B1 (en) | 2015-06-24 |
JP4588325B2 (ja) | 2010-12-01 |
EP1499333A4 (en) | 2008-05-28 |
PL373002A1 (en) | 2005-08-08 |
AU2003216368B2 (en) | 2007-08-09 |
CA2481972A1 (en) | 2003-10-30 |
US20030219497A1 (en) | 2003-11-27 |
JP2005531534A (ja) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA85041C2 (ru) | Способ лечения кишечной непроходимости | |
HRP20041071A2 (en) | Methods of treating hepatitis | |
UA86570C2 (ru) | Способ лечения некротизирующего энтероколита | |
PL373229A1 (en) | Method and apparatus for the administration of co | |
RS20050344A (en) | Treatment for hemorrhagic shock | |
WO2003103585A3 (en) | METHODS OF TREATING ANGIOGENESIS, TUMOR GROWTH AND METASTASES | |
RS20060320A (en) | Substituted indazole-o-glucosides | |
IL220043A0 (en) | Methods for producing ??-galactosidase a compositions | |
TW200407305A (en) | Novel compounds | |
UA87991C2 (en) | Substituted indole-o-glucosides | |
UA92894C2 (ru) | Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата | |
MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
TW200700071A (en) | Novel use | |
PL1694354T3 (pl) | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny | |
UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
HK1091816A1 (en) | Diphenylurea derivatives and their use as chloride channel blockers | |
MXPA05005915A (es) | Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas. | |
RS20060049A (en) | Novel n-substituted indolyl-3-glycoxylic acid amides, use thereof as a medicament and method for the production thereof | |
UA34199A (ru) | Способ лечения пародонтита | |
UA54880C2 (ru) | (s)-2-амино-5-гуанидинопентановой кислоты (s)-2-аминоглутарат (l-аргинина l-глутамат), обладающий гепатопротекторным, гипоаммониемическим и детоксикационным действием, способ его получения и фармацевтическая композиция на его основе | |
UA84701C2 (ru) | Замещенные индолы, способ их получения, их использования | |
MY135292A (en) | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
HK1093962A1 (en) | L-(-)-moprolol-l-(+)-tartrate |